Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos and adult toys.
Popular Articles

Stem Cell Industry Expert Praises, Encourages Continued Progress On Legislation To Promote Benefits Of Cord Blood
Mercedes Walton, CEO of Cryo-Cell International, one of the largest and most established family cord blood banks, is praising legislative progress to date and encouraging continued momentum for existing bills through the second half of the year. H.R. 1718, the "Family Cord Blood Banking Act," and H.R. 2107, the "Cord Blood Education and Awareness Act of 2009" would continue to build on the progress from the first half of the year to enable and promote the continued research, public awareness and tax benefits related to storing and using cord blood, all of which provide great benefit to families across America.
buy viagra
64% Of Total Polyps Detected By Conventional Colonoscopy Are Diagnosed By Minimally Invasive Colon Capsule Endoscopy
Capsule endoscopy for exploring the colon in a minimally invasive manner diagnoses 64% of all lesions located by means of conventional colonoscopy. According to a study published in The New England Journal of Medicine - the specialised medical journal with greatest international impact -, the new device would need technical improvements to achieve similar efficacy to the conventional procedure undertaken with a colonoscopy and to date considered a "gold standard" technique for this medical discipline, given that this is what currently provides the most reliable results. It has to be added that, moreover, conventional colonoscopy enables the undertaking of a diagnosis of the colon as well as practicing therapeutic procedures, such as the in situ extirpation of polyps during exploration or the obtaining of a biopsy when required.
News of the day
Reps. Ryan, DeLauro To Introduce Bill To Reduce Need For Abortion
Reps. Tim Ryan (D-Ohio) and Rosa DeLauro (D-Conn.) on Thursday will be joined by leaders of the Planned Parenthood Federation of America and NARAL Pro-Choice America in announcing the latest version of a bill that aims to reduce the need for abortion by preventing unintended pregnancies, among other measures, Time reports (Sullivan, Time, 7/23). Ryan and DeLauro first introduced a version of the bill in 2006 (Crary, AP/San Francisco Chronicle, 7/22). However, this version "represents a dramatic break from nearly four decades" of political debate since Roe v. Wade, as both conservative antiabortion-rights groups and abortion-rights advocates have expressed support, according to Time (Time, 7/23).The bill would increase support for comprehensive sex education programs, improve access to contraception, expand Medicaid family planning coverage, increase programs for pregnant or parenting college students, and expand adoption assistance. The Congressional Budget Office has not yet conducted a cost-analysis of the bill, the AP/San Francisco Chronicle reports (AP/San Francisco Chronicle, 7/22). In developing the bill, Ryan sought the help of Rachel Laser, director of culture programs at the policy and strategy think-tank Third Way. According to Time, Laser worked with advocates on both sides and modified the bill to help gather their support, while preventing the measure from becoming "uselessly watered down or split into two."DeLauro noted, "We had to reach a level of trust" with people on both sides and allow them time to become more receptive to the bill"s goals, adding, "Because so often this issue has been one about which there was nothing other than trying to score political points." DeLauro said she hopes the Obama administration will look to the bill for guidance as it crafts its strategy for reducing the need for abortion and preventing unintended pregnancies. President Obama is expected to make an announcement about the plan next month, according to Time (Time, 7/23).DeLauro and Ryan also noted that Rahm Emanuel, Obama"s chief of staff, endorsed an earlier version of the bill when he served in the House, which they hope could mean that Obama would support their measure. DeLauro said, "This is a bill that seems to mesh with the president"s interests," adding, "I see no reason why the White House could not endorse it."Joshua DuBois, director of the White House Office of Faith-Based and Neighborhood Partnerships, said the administration is still reviewing the information it has gathered in recent meetings with representatives on both sides of the abortion debate.Laurie Rubiner, director of Planned Parenthood"s Washington, D.C., office, said "This isn"t a radical bill," adding, "It only seems radical because it"s been so long that we could have a constructive conversation ... with both pro-choice and anti-choice groups around the table."The Rev. Joel Hunter -- an antiabortion-rights evangelical pastor in Orlando, Fla., who serves on the White House Faith-Based Advisory Council -- called the bill "a landmark bill for the culture wars -- a prototype for how we can approach things in the future." He said the bill"s strengths were in its appeals to both liberal and conservative beliefs, adding, "When you realize you need someone who"s been an adversary to help you advance your own projects, that"s a big deal" (AP/San Francisco Chronicle, 7/22).
Sexual Health

Sexually Transmitted HPV Linked To Certain Head & Neck Cancers

Researchers at Roswell Park Cancer Institute (RPCI) in Buffalo, New York, are strongly advocating a national discussion about the need to vaccinate both young men and women against HPV 16 to prevent head & neck cancers. The call comes amid growing evidence that certain cancers of the head and neck are strongly linked to HPV 16, a specific strain of the human papillomavirus (HPV) that is one of the most common sexually transmitted diseases in the United States. It is estimated that approximately 70% of Americans, both men and women, will be infected with HPV at some point in their lives. The types of cancer associated with HPV 16 occur mostly at the back (base) of the tongue, in the tonsils, and in the soft palate at the back of the throat, according to Thom Loree, MD, Chair of RPCI"s Department of Head & Neck Surgery. Over the past 10 years, members of RPCI"s Head & Neck Department have seen a threefold increase in the number of throat cancers they treat. In 2007, Roswell Park researchers began testing all head and neck tumors treated at the Buffalo-based comprehensive cancer center for the presence of HPV DNA, says Saurin Popat, MD, FRCSC, FACS, Attending Surgeon in Head & Neck and Plastic & Reconstructive Surgery, RPCI. RPCI is one of few institutions in the nation to do so. Data from the ongoing testing have been combined with data from archived tumor samples to provide a clearer picture of how many head and neck cancers treated at RPCI test positive for HPV. To date, the total is around 50 to 60 percent. There are more than 100 types of HPV -- each identified by number -- but only 70 have been described so far, explains Popat. Some HPV viruses, including 16 and 18, are transmitted sexually -- not just through sexual intercourse, but through any skin-to-skin contact involving the mouth, vagina, vulva (the external female genitalia), penis, anus, or fingers. HPV 16 and HPV 18 were previously identified as the cause of most cases of cervical cancer in the U.S. HPV has also been implicated in the development of some cancers of the vulva, vagina, anus, penis, and perineum (the area between the genitals and anus). There is no cure for HPV, just as there is no cure for the common cold. In most people, an HPV infection will clear up on its own, but it can be passed on to other people during the infection period -- just as with the common cold. In some cases, the person may continue to be infected for decades without any symptoms. During that time, the infected person can infect others without knowing it. Over time, this "silent," chronic HPV infection increases the risk of developing certain cancers. In 2006, the FDA approved the use of Gardasil, a vaccine that protects against HPV 6, 11, 16 and 18, for females between the ages of 9 and 26, to help prevent cancers of the cervix, vulva, and vagina, as well as genital warts. The FDA has not approved the vaccine for males. The issue of extending approval to males to protect against HPV related cancers is under review, with a decision expected in June 2009. Loree, Popat, and their RPCI colleagues see compelling evidence for extending the vaccine"s protection to boys. Says Popat, "The side effects of the vaccine are so small, and the potential benefits are great." He notes that patients with throat cancer "have to undergo major treatment lasting several months, with an additional four to six months of recovery. Their ability to speak and swallow is affected. Generally, they do very well; however, it is a long, challenging road." Based on the evidence to date, Loree says that "with increased vaccination against HPV, you"ll see a decrease in cervical cancer and in throat cancers." He says if everyone stopped smoking and using tobacco in any form, and also got vaccinated against HPV, "we could eliminate head and neck cancers, and I"d be out of business." The American Cancer Society estimates that 35,310 new cases of oral and oropharyngeal cancer are diagnosed every year -- 25,310 of those in men -- and 7,590 people, including 5,210 men, die of those cancers. Smoking, the use of chewing tobacco, and heavy alcohol use remain the leading causes of cancers of the head and neck. The mission of Roswell Park Cancer Institute (RPCI) is to understand, prevent and cure cancer. RPCI, founded in 1898, was one of the first cancer centers in the country to be named a National Cancer Institute-designated comprehensive cancer center and remains the only facility with this designation in Upstate New York. The Institute is a member of the prestigious National Comprehensive Cancer Network, an alliance of the nation"s leading cancer centers; maintains affiliate sites; and is a partner in national and international collaborative programs. Roswell Park Cancer Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009